Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection
Author:
Funder
Pulmocide Ltd.
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-019-45890-w.pdf
Reference32 articles.
1. Dagenais, T. R. T. & Keller, N. P. Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis. Clin Microbiol Rev 22, 447–465, https://doi.org/10.1128/cmr.00055-08 (2009).
2. Patterson, T. F. et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 63, e1–e60, https://doi.org/10.1093/cid/ciw326 (2016).
3. Rodvold, K. A., Yoo, L. & George, J. M. Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antifungal, antitubercular and miscellaneous anti-infective agents. Clinical pharmacokinetics 50, 689–704, https://doi.org/10.2165/11592900-000000000-00000 (2011).
4. Hoeben, B. J. et al. In Vivo Efficacy of Aerosolized Nanostructured Itraconazole Formulations for Prevention of Invasive Pulmonary Aspergillosis. Antimicrob Agents Chemother 50, 1552–1554, https://doi.org/10.1128/aac.50.4.1552-1554.2006 (2006).
5. Hilberg, O. et al. Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis. The European respiratory journal 40, 271–273, https://doi.org/10.1183/09031936.00163511 (2012).
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease;Clinical Microbiology Reviews;2024-06-13
2. Contemporary Management of Pediatric Invasive Fungal Rhinosinusitis;Current Infectious Disease Reports;2024-06-08
3. Alternative Oxidase – Aid or obstacle to combat the rise of fungal pathogens?;Biochimica et Biophysica Acta (BBA) - Bioenergetics;2024-04
4. New Antifungal Drugs: Discovery and Therapeutic Potential;Fungi Bioactive Metabolites;2024
5. Food and Drug Administration (FDA) Public Workshop Summary—Addressing Challenges in Inhaled Antifungal Drug Development;Clinical Infectious Diseases;2023-10-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3